Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression

Lack of association between ABCC2 gene variants and treatment response in epilepsy

(2012) Eva Hilger et al.   PHARMACOGENOMICS

ABCC2/Abcc2: a multispecific transporter with dominant excretory functions

(2010) Katalin Jemnitz et al.   DRUG METABOLISM REVIEWS

Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients

(2010) Baohui Han et al.   LUNG CANCER

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

(2010) S Laechelt et al.   PHARMACOGENOMICS JOURNAL

Association of the c.3972C>T Variant of the Multidrug Resistance-Associated Protein 2 Gene (MRP2/ABCC2) with Susceptibility to Bile Duct Cancer

(2009) A. Höblinger et al.   DIGESTION

Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics

(2009) Federico Innocenti et al.   JOURNAL OF CLINICAL ONCOLOGY

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

(2009) Mike Ufer et al.   Pharmacogenetics and Genomics

Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)

(2008) Ken-ichi Fujita et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

(2008) Sierk Haenisch et al.   Pharmacogenetics and Genomics

Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2)

(2008) Ishtiaq Qadri et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY